Skip to main content
UCL Ventures Navigate back to homepage
Find your Business Manager

Main navigation

  • Your route to market

    Your route to market

    We guide UCL academics, researchers and clinicians to get their research to market.

    Disclose an idea
    • Getting started An introduction to commercialisation and next steps
    • Our collaborative approach How we work with you to get to market
    • What you can expect Demystifying the process of commercialisation
    • Options to move forwards Explore the different pathways to market
      • Protect your idea
      • Create a company
      • Licensing your invention
      • Routes to social impact
    • Funding & support The financial and practical help that we can offer
      • Help managing your project
      • Training & tools
      • Common questions
  • Explore innovations

    Explore innovations

    Our portfolio and technologies span AI and quantum, to gene therapies to consumer products.

    • Spinout portfolio Browse our portfolio of spinout companies, based on UCL research
    • Our expertise & pipeline The sectors we span and therapeutics in development
    • Social Ventures Ventures driving impact in communities
    • License a technology Opportunities & collaborations with UCL's world-class research
  • Global impact

    Global impact

    How UCL research is changing the way the world lives, works and thrives.

    • Inspiring stories Real-world impact and successes, supported by UCL Ventures
    • Impact Report Our annual report showcases how UCL research is going beyond the university
    • Supporting innovation at UCL Understand our role in the innovation ecosystem
  • Investors & business

    Investors & business

    Opportunities for collaboration across UCL's world-class research

    • Why partner with UCL Ventures With over 30 years in commercialisation, we have a strong track record
    • Our portfolio View our spinout companies across all sectors
  • News & events

    News & events

    The latest news and events from our team and portfolio

    • Current page: News & views Stay up to date with the latest insights and announcements
    • Events Where you can find us across UCL and external events
  • Get in touch

    Get in touch

    Contact our team of experts for all your queries and needs

    • Speak to the team Choose your enquiry type to reach the right team
Find your Business Manager

Quantum algorithm developer Phasecraft raises $34 million Series B

The funding will help bring about industry applications sooner.

2 September 2025

Breadcrumb trail

  1. Home
  2. News & events
  3. News & views
  4. Quantum algorithm developer Phasecraft raises $34 million Series B

UCL spinout Phasecraft, a quantum algorithms company, has secured $34 million in Series B funding, to accelerate the real-world applications of quantum algorithms.

This major funding round, announced today, was co-led by Plural, existing investor Playground Global, and Novo Holdings’ Quantum Fund, alongside support from existing investors AlbionVC, Latitude and Parkwalk Advisors.

Phasecraft was created as a spinout with the support of UCL Ventures, UCL’s commercialisation company in 2019. Its founders are leading quantum scientists Toby Cubitt and John Morton, part of UCL’s Quantum Science and Technology Institute, and Ashley Montanaro from the University of Bristol; with their expertise and leadership, Phasecraft has become the world’s leading quantum algorithms company.

Quantum computing hardware and software are converging towards commercial application and use – but ultra-efficient algorithms, like those developed by Phasecraft, are needed to unlock its full potential.

The company seeks to redesign such algorithms, while ensuring they will work with the imperfect quantum computers in existence and are hardware agnostic. When used as a partner to standard computing, the Noisy Intermediate Scale Quantum devices (NISQ) of today can begin to tackle previously inaccessible problems, rather than waiting for perfect hardware.

This brings applications to industry sooner than anticipated and makes quantum computing more practically applicable for real world applications.

Phasecraft’s quantum approach is already making positive strides in:

  • material science, by making simulating materials millions of times more efficient
  • biological research by applying quantum computing to key biochemical processes relevant to drug development for genetic conditions
  • and energy resilience by optimizing energy networks.

Phasecraft’s technology is already being worked with by the likes of speciality materials developer Johnson Matthey, solar cell developer Oxford PV, the UK’s National Energy System Operator (NESO), and leading telecommunications provider BT, while top-tier quantum hardware firms such as Google, IBM, Quantinuum, and QuEra are collaborators.

This funding series takes investment in Phasecraft to more than $50 million, inclusive of grant funding, and will enable the company to increase its R&D function to build real world solutions for end users.

UCL Ventures footer

About UCL Ventures

  • Our people
  • What we do
  • Who we are
  • Our culture

Forms & Resources

  • Publications and downloads

Accreditations

  • Cyber essentials
    cyber essentials logo
  • Living wage
    living wage employer logo
UCL Ventures

UCL Ventures Limited (Company Registration No: 02776963) is a wholly-owned subsidiary of University College London. 

Registered office: 
University College London
Gower Street
London
WC1E 6BT

UCL social media menu

  • Link to Linkedin
Back to top

Legal

  • Cookie policy
  • Freedom of information
  • Privacy policy
  • Rules of website use

© 2026 UCL Business Ltd